Fintech Asia News Feed
Discover more about the world of artificial intelligence, machine learning, and blockchain through our carefully curated news feed.
AI Helps Penn Engineers Improve a Gene-Editing Tool, Even with Limited Data
Gene editing has promised a way to treat some diseases, including inherited genetic disorders, blood conditions and cancer, at their genetic roots. But even as tools such as CRISPR, which allows scientists to alter DNA sequences and modify gene function with high precision, have become increasingly powerful, a practical challenge remains: Many genome editors are
In an Age of Deep Tech, The City Summit Bets on Human Connections
Insider Brief The sixth annual City Quantum & AI Summit will bring leaders from technology, defense, finance, government and research to London’s Mansion House on Oct. 7. The program will examine quantum and AI applications and risks across cybersecurity, finance, life sciences, space and national security. The summit will emphasize plain-language discussions, cross-sector networking and
Microsoft, Azure & AI Tech Combat California Wildfire Risks
Microsoft is investing in AI-powered wildfire detection, with Juan Lavista Ferres, CVP & Chief Data Scientist, speaking on reducing environmental damage According to NASA, everyone on Earth is touched by the effects of climate change, such as hotter temperatures, shifts in rain patterns and sea level rise. NASA says that there is unequivocal evidence that
Deep-Learning Tool Uses Long-Read Sequencing to Detect Cancer Mutations
By Bio-IT World News Staff September 2, 2026 | Analyzing genetic changes in cancer cells can provide insight into how tumors develop and inform precision oncology. However, identifying cancer-related mutations can be challenging, particularly when they occur at low frequencies or in complex regions of the genome. Short-read sequencing can struggle with repetitive and difficult-to-map
The true cost of AI (Part One) – Chris Skinner’s blog
There is a rather awkward conversation beginning in boardrooms about artificial intelligence. For the last few years, the question has been what AI can do, how quickly companies can deploy it and how many people it might replace, but the question now landing on the CFO’s desk is much simpler: how much is this stuff
Frontiers | Artificial intelligence-assisted type 2 inflammatory endotyping in CRSwNP: from Sinus CT and digital pathology to biologic decision support
Abstract Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous rhinologic disease frequently driven by type 2 inflammation, yet routine clinical phenotyping remains insufficient for endotype-informed management. Conventional markers, including blood eosinophils, serum immunoglobulin E (IgE), fractional exhaled nitric oxide, tissue eosinophilia, nasal polyp score, and sinus computed tomography (CT) scores, provide useful but incomplete
‘If you build something vastly smarter than you, it better be on your side’: can we stop AI from deceiving us?
In November 2023 – a lifetime ago in the field of artificial intelligence – some of the most powerful people in the world descended on Bletchley Park, the wartime codebreaking hub in Buckinghamshire, to talk about AI safety. In attendance were the then US vice-president, Kamala Harris, the AI bosses Sam Altman and Dario Amodei
Machine Learning Models for Early Autism Spectrum Disorder Detection: Systematic Review With a Pediatric and Engineering Perspective
Home Specialties Specialties Browse Articles Posters Abstracts Cureus Collections Specialties Allergy / Immunology Anatomy Anesthesiology Cardiac / Thoracic / Vascular Surgery Cardiology Dentistry Dermatology Emergency Medicine Endocrinology / Diabetes / Metabolism Environmental Health Epidemiology / Public Health Family / General Practice Forensic Medicine Gastroenterology General Surgery Genetics Geriatrics Healthcare Technology Health Policy Hematology HIV /







